Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
Drug-induced abnormalities
MeSH D000014 - drug-induced abnormalities
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D000013:
Congenital abnormalities
1 Company
1 Drug
$
Success rate
D000014:
Drug-induced abnormalities
79 Companies
11 Drugs
$
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
0
%
0/0
Phase 2
0
%
0/0
Phase 3
100
%
7/7
Approved:
7
Overall Success rate:
0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
AstraZeneca
Budesonide
,
Formoterol
,
Formoterol fumarate dihydrate
,
Glycopyrrolate
Novartis
Glycopyrrolate
,
Indacaterol
1
2
3
4
5
6
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use